Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Sponsor
Alma Lasers Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01645345
Collaborator
(none)
200
3
1
8
66.7
8.4

Study Details

Study Description

Brief Summary

To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

Condition or Disease Intervention/Treatment Phase
  • Device: Alma Lasers Accent RF Pixel handpiece
N/A

Detailed Description

The study design will be a prospective open label study. Up to 20 subjects of both genders with acne scars and/or wrinkles in the face will be recruited. The subjects will be treated once on clean acne scarred skin and three times on the the wrinkled skin with the Pixel RF handpiece. Each treatment duration will be approximately 30 minutes. The initial power and number of passes parameters shall be set according to the clinical indication and skin type of the subject treated (as well as the results of test sites).

Clinical improvement will be assessed by the investigator physician from the visual appearance of the treated area according to the following scale: -1 for exacerbation, 0 no change, 1 for 1%-25% improvement, 2 for 25%-50% improvement, 3 for 50%-75% improvement, and 4 for 75%-99% improvement. Adverse side effects will be scored by clinical evaluation of erythema, edema, and burns. Real-time assessments will be made as well by the investigators. Treatment and results will be documented in a Case Report Form and follow-up sessions (1, 5 days after the treatment and 1 month and 3 months after the treatment).

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: RF Pixel handpiece treatment

There is only one arm, and that is a treatment arm. For patients with wrinkles and acne scars, they are being treated with the RF Pixel handpiece to decrease the appearance of these cosmetic deficiencies. The improvement is documented in before and after photographs.

Device: Alma Lasers Accent RF Pixel handpiece
Treatment with fractionated RF Pixel device

Outcome Measures

Primary Outcome Measures

  1. Improvement in the appearance of wrinkles and acne scars [3 months]

    Visual assessment of the improvement in the appearance of wrinkles and acne scars after treatment with fractionated RF.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Subjects meeting the following inclusion criteria may participate:

  • Male or female subject 18-60 years of age.

  • Clinically documented rolling and boxcar acne scars and/or wrinkles score of 2 or 3 per the Rao-Goldman scale (see section 6.5.1 for wrinkle classification).

  • Limitation to acne scared and wrinkles area: face.

  • Patients must commit to all follow-up visits.

Exclusion Criteria:
Subjects meeting any of the following criteria will be excluded from participation:
  • Bacterial or viral infection

  • Impaired immune system

  • Isotretinoin (Accutane, Amnesteem, Claravis, and Sotret) in the past 6 months

  • Scleroderma

  • Extensive radiation therapy

  • Burns in the treatment area

  • Poor healing in the treatment area

  • Metal implants near the treatment area

  • Implantable pacemaker or automatic defibrillator/cardioverter (AICD)

  • Ablative/non-ablative cosmetic intervention (deep peeling) in the past 3 months in the areas to be treated

  • Active cancer

  • Active collagen or vascular disease

  • Pregnancy or IVF procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Metropolitan MD Glenview Illinois United States 60025
2 Dr. Zimmerman Las Vegas Nevada United States 89148
3 Victoria Cirillo-Hyland Bryn Mawr Pennsylvania United States 19010

Sponsors and Collaborators

  • Alma Lasers Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alma Lasers Inc.
ClinicalTrials.gov Identifier:
NCT01645345
Other Study ID Numbers:
  • 022012
First Posted:
Jul 20, 2012
Last Update Posted:
Aug 24, 2020
Last Verified:
Jul 1, 2012
Keywords provided by Alma Lasers Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2020